DERMASEQ Trademark

Trademark Overview

On Tuesday, December 8, 2015, a trademark application was filed for DERMASEQ with the United States Patent and Trademark Office. The USPTO has given the DERMASEQ trademark a serial number of 86842314. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Tuesday, September 27, 2016. This trademark is owned by Adaptive Biotechnologies Corporation. The DERMASEQ trademark is filed in the Computer & Software Services & Scientific Services and Medical & Beauty Services & Agricultural Services categories with the following description:

Medical and scientific research in the fields of cutaneous T-cell lymphoma and skin-related cancers and diagnosing and treating same; scientific research, development, engineering, testing, and analytical services for diagnosing and treating cutaneous T-cell lymphoma and skin-related cancers; providing diagnostic assays and diagnostic or prognostic testing for diagnosing cutaneous T-cell lymphoma and skin-related cancers; providing analysis, evaluation, and clinical reports of a patient's condition with regard to cutaneous T-cell lymphoma and skin-related cancers; providing diagnostic assays and diagnostic or prognostic testing for cutaneous T-cell lymphoma and skin-related cancers, and the analysis, evaluation, and reports of those test results to help healthcare professionals determine a patient's diagnosis, prognosis or treatment, to assess the effectiveness of patient treatments, and to revise future treatments accordingly; research and development of diagnostic test kits for detec...

Medical services; medical analysis and diagnostic services; medical diagnostic services, namely, medical testing for diagnostic or treatment purposes; medical diagnostic services, namely, medical diagnostic testing, monitoring and reporting services; providing medical diagnostic testing for the detection, diagnosis, and treatment of cutaneous T-cell lymphoma and skin-related cancers; providing medical testing for immune responses to immunotherapy or cancer treatment
dermaseq

General Information

Serial Number86842314
Word MarkDERMASEQ
Filing DateTuesday, December 8, 2015
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateTuesday, September 27, 2016
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesMedical and scientific research in the fields of cutaneous T-cell lymphoma and skin-related cancers and diagnosing and treating same; scientific research, development, engineering, testing, and analytical services for diagnosing and treating cutaneous T-cell lymphoma and skin-related cancers; providing diagnostic assays and diagnostic or prognostic testing for diagnosing cutaneous T-cell lymphoma and skin-related cancers; providing analysis, evaluation, and clinical reports of a patient's condition with regard to cutaneous T-cell lymphoma and skin-related cancers; providing diagnostic assays and diagnostic or prognostic testing for cutaneous T-cell lymphoma and skin-related cancers, and the analysis, evaluation, and reports of those test results to help healthcare professionals determine a patient's diagnosis, prognosis or treatment, to assess the effectiveness of patient treatments, and to revise future treatments accordingly; research and development of diagnostic test kits for detecting and diagnosing cutaneous T-cell lymphoma and skin-related cancers; laboratory research and testing services relating to detecting and diagnosing cutaneous T-cell lymphoma and skin-related cancers; computer services, namely, software as a service (SAAS) services featuring software that provides information, test results for detecting and diagnosing cutaneous T-cell lymphoma and skin-related cancers, and the analysis, evaluation, and reporting of those test results to healthcare professionals to determine a patient's clinical diagnosis, prognosis or treatment, to assess the effectiveness of patient treatments, and to revise future treatments accordingly
Goods and ServicesMedical services; medical analysis and diagnostic services; medical diagnostic services, namely, medical testing for diagnostic or treatment purposes; medical diagnostic services, namely, medical diagnostic testing, monitoring and reporting services; providing medical diagnostic testing for the detection, diagnosis, and treatment of cutaneous T-cell lymphoma and skin-related cancers; providing medical testing for immune responses to immunotherapy or cancer treatment

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, December 11, 2015
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE
International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, December 11, 2015
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAdaptive Biotechnologies Corporation
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSeattle, WA 98102

Trademark Events

Event DateEvent Description
Tuesday, February 13, 2018TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, September 27, 2016ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Tuesday, September 27, 2016ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Friday, March 25, 2016NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, March 25, 2016NON-FINAL ACTION E-MAILED
Friday, March 25, 2016NON-FINAL ACTION WRITTEN
Thursday, March 24, 2016ASSIGNED TO EXAMINER
Friday, December 11, 2015NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, December 11, 2015NEW APPLICATION ENTERED IN TRAM

Related Keywords

dermaseq diagnostic medical testing related services skin cancers lymphoma cell cutaneous